Tag: Oncology

HCG buys oncology hospital labs and clinical trials business of Strand Lifesciences

businessnewstoday- September 5, 2021 0

HealthCare Global Enterprises Limited (HCG) said that it has acquired oncology hospital labs and clinical trials business of Strand Lifesciences for around INR 81 crores ... Read More

Dr. Reddy’s Labs signs deal worth up to $150m to sell E7777 rights to Citius

businessnewstoday- September 4, 2021 0

Dr. Reddy's Laboratories (Dr. Reddy's Labs) has agreed to divest its rights to E7777, an engineered IL-2-diphtheria toxin fusion protein, and certain related assets to ... Read More

Pfizer to acquire immuno-oncology company Trillium Therapeutics for $2.2bn

businessnewstoday- August 27, 2021 0

US pharma giant Pfizer has agreed to acquire Trillium Therapeutics, a publicly listed Canadian clinical stage immuno-oncology company, for $18.5 per share or $2.26 billion ... Read More

Infosys opens Rs 25.5cr OPD block at Kidwai Memorial Institute of Oncology

businessnewstoday- August 24, 2021 0

Infosys said that its philanthropic and CSR arm — Infosys Foundation has wrapped up construction of a multi-disciplinary outpatient department (OPD) block at the Kidwai ... Read More

Lantern Pharma bags FDA orphan drug status for LP-184 in pancreatic cancer

businessnewstoday- August 11, 2021 0

Lantern Pharma has secured orphan drug designation for its small molecule drug candidate LP-184 from the US Food and Drug Administration (FDA) for the treatment ... Read More

Race Oncology doses first patient in phase 1b/2 AML trial of FluCloZan

businessnewstoday- August 9, 2021 0

Race Oncology has dosed the first patient in the phase 1b/2 trial of its Zantrene (bisantrene dihydrochloride) in combination with Fludarabine and Clofarabine (FluCloZan) in ... Read More

AbbVie’s ibrutinib, venetoclax combo succeeds in phase 3 GLOW study

businessnewstoday- June 13, 2021 0

AbbVie said that the phase 3 GLOW study in chronic lymphocytic leukemia (CLL) investigating the combination of IMBRUVICA (ibrutinib) plus VENCLEXTA/VENCLYXTO (venetoclax) (I+V) has met ... Read More

LUMAKRAS FDA approval : Amgen bags approval in KRAS G12C-mutated NSCLC

businessnewstoday- May 29, 2021 0

LUMAKRAS FDA approval : Amgen has bagged accelerated approval from the US Food and Drug Administration (FDA) for LUMAKRAS (sotorasib) for the treatment of a ... Read More

Chronos-3 trial results : Aliqopa, rituximab combo meets primary endpoint of PFS, says Bayer

businessnewstoday- April 11, 2021 0

Chronos-3 trial results : Bayer said that the investigational combination of Aliqopa (copanlisib) and rituximab considerably increased progression-free survival (PFS) in patients having relapsed indolent ... Read More

Pyxis Oncology raises $152m in Series B round for cancer therapies

businessnewstoday- March 30, 2021 0

Pyxis Oncology, a Boston-based biotech company, has raised $152 million in a Series B financing round co-led by Arix Bioscience and RTW Investments. The company ... Read More